Driven by our purpose to make the world a healthier place for all people, we’ve worked to improve health equity and advance equitable access to care. Last week, we brought together leaders, advocates and changemakers to share insights at our inaugural Global Health Equity Summit.
Gilead Sciences
Biotechnology Research
Foster City, CA 619,107 followers
Creating Possible
About us
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines
- Website
-
http://www.gilead.com
External link for Gilead Sciences
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Foster City, CA
- Type
- Public Company
- Founded
- 1987
Locations
Employees at Gilead Sciences
Updates
-
Discovering a cure for #HIV is one of the greatest scientific challenges of our time. But our scientists are driven to change the future and every day we’re one step closer. #Innovation | #HIVAwareness
-
#GileadNews: New Gilead and Kite Oncology data will showcase our ongoing commitment to developing differentiated approaches to help transform how cancer is treated. #ASCO24 https://gilead.inc/3UtJUzT
-
We celebrate and uplift the Asian American Pacific Islander community, whose diverse traditions are woven together by the strength of the voices we amplify. Our colleagues enrich our perspectives as we continue to support the communities we serve. #AAPIHeritageMonth
-
Today, Flavius Martin, Executive Vice President of Research, represented Gilead at the 8th Annual Stanford Drug Discovery Symposium. In front of a standing-room-only audience, he showcased our innovative approach to drug discovery and shared the importance of collaborations and partnerships in scientific research. #SDDS2024
-
Forbes has listed Gilead as one of America’s #BestEmployersforDiversity. We believe that by championing inclusion and diversity, we not only enrich our workplace but also drive groundbreaking advancements in science. “Continuing to hold ourselves accountable in building an environment that fosters inclusion is essential, and this recognition is especially meaningful as it's based on feedback from our incredible employees and community in addition to data." - Jyoti Mehra, Executive Vice President of Human Resources.
-
-
#GileadNews: The U.S. FDA has approved a label update for one of our #HIV treatments to include data in pregnant people with HIV who are virologically suppressed. As part of our commitment to person-centered innovation, this advances our efforts to address the needs of underrepresented communities in clinical research. Read more: https://gilead.inc/3wihCQL
-
#GileadNews: Read the press release to learn more about our financial results from last quarter. https://gilead.inc/3UwvGzC
-
“The cultural needs that our patients face really stand out, therefore we knew we had to do more to serve Native American patients in a genuine, authentic and culturally sensitive way.” A Gilead grant is helping Native American women with breast cancer manage an often-complex tribal healthcare system by expanding access and removing barriers to care. Learn more about the health navigator program and how it aims to transform breast cancer care in Native communities. https://gilead.inc/4aNCBdq
-
-
Creating a healthier world for all people starts by protecting the health of our planet. Joydeep Ganguly, SVP of Corporate Operations, shares how we’re working across every aspect of our operation to reduce impact and protect the long-term sustainability of our business. Read our 2023 ESG report to learn more. www.gilead.com #EarthDay | #GileadForGood
Affiliated pages
Similar pages
Browse jobs
Stock
GILD
NASDAQ
20 minutes delay
$67.90
0.18 (0.266%)
- Open
- 67.72
- Low
- 67.38
- High
- 68.038
Data from Refinitiv
See more info on